
COVID-19: Facts, History, Symptoms, and Prevention
Stay informed about COVID-19 with key information on the virus, including its origin, symptoms, incubation period, mode of infection, and comparison to past outbreaks like SARS. Learn about the global impact, prevention strategies, and debunked myths to protect yourself and others.
Download Presentation

Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
CORONA VIRUS- (FACTSHEET)
FACTS: NEW CASES OF INFECTION WITH A NEW CORONAVIRUS WHICH EMERGED IN THE CHINESE CITY OF WUHAN, ARE BEING REPORTED DAILY AROUND THE WORLD. THIS VIRUS IS KNOWN AS COVID-19 (CORONA VIRUS DISEASE 2019). THIS NAME WAS GIVEN ON 11TH FEB. 2020 BY WHO. IN MAINLAND CHINA,2,345 (ABOUT 3000) PEOPLE HAVE DIED, WHILE 76,288 (ABOUT 1 LAKH) INFECTIONS HAVE BEEN CONFIRMED, ACCORDING TO GOVERNMENT FIGURES.
HISTORY: SARS VIRUS SPREAD IN 2003; DEATH RATE WAS 10%. CASES ARE RISING IN VARIOUS COUNTRIES. ABOUT 30 COUNTRIES ARE AFFECTED. INTERNATIONAL EPIDEMIOLOGICAL SURVEY REPORTS STATED THAT THE VIRUS WILL SOON CONVERT INTO PANDEMIC.
INCUBATION PERIOD 2 TO 11 DAYS FLU like symptoms are seen on second day. On day 4 medical treatment becomes necessary; shortness of breath and early pneumonia. Critically ill by day seven. After day 11, most patients who survive are on their way to recovery.
SYMPTOMS RESPIRATORY SYMPTOMS, FEVER, COUGH, SHORTNESS OF BREATH AND BREATHING DIFFICULTIES. IN MORE SEVERE CASES, INFECTION CAN CAUSE PNEUMONIA, SEVERE ACUTE RESPIRATORY SYNDROME, KIDNEY FAILURE AND EVEN DEATH.
DEATH RATE 2% LESS DEADLY THAN SARS WHICH HAD 10% DEATH RATE
NAME OF THE VIRUS COVID-19 by the World Health Organization. (The virus itself has been named SARS-CoV-2 by the International Committee on Taxonomy of Viruses).
MODE OF INFECTION The new coronavirus is spread through droplets and surfaces. It may travel up to six feet from someone who is sneezing or coughing.
MODE OF INFECTION INITIALLY THE VIRUS WAS A ZOONOTIC. SARS (SEVERE ACUTE RESPIRATORY SYNDROME) VIRUS CAME FROM CATS TO HUMANS; CAME FROM HONG KONG, CHINA. MERS (MIDDLE EAST RESPIRATORY SYNDROME) VIRUS CAME FROM CAMELS TO HUMANS. CAME FROM SAUDI ARABIA.
MYTHS: The virus can circulate through the air. Note: If you have an infected person in the front of the plane, for instance, and you re in the back of the plane, your risk is close to zero simply because the area of exposure is thought to be roughly six feet from the infected person. The virus can spread via eating ice-cream.
MAIN REASON FOR SPREAD: CLOSE CONTACT WITH AN INFECTIOUS PERSON, SUCH AS SHAKING HANDS, OR TOUCHING A DOORKNOB, TABLETOP OR OTHER SURFACES TOUCHED BY AN INFECTIOUS PERSON, AND THEN TOUCHING YOUR NOSE, EYES, OR MOUTH CAN ALSO TRANSMIT THE VIRUS.
PREVENTION: Regular hand washing, Covering mouth and nose when coughing and sneezing, Thoroughly cooking meat and eggs; non-vegetarian food. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing. Maintain at least 1 meter distance between yourself and other people. Strictly avoid any contact with other animals in the market (e.g., stray cats and dogs, rodents, birds, bats). Avoid contact with potentially contaminated animal waste or fluids on the soil or structures of shops and market facilities.
TREATMENTS: Favilavir, the first approved coronavirus drug in China mRNA-1273 vaccine by Moderna and Vaccine Research Center INO-4800 by Inovio Pharmaceuticals and Beijing Advaccine Biotechnology